Tan Zhang

A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults

Haifeng Song, Q. Wang, Xiao-yan Nie, 2020, Expert opinion on investigational drugs.

The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis.

Lu-jin Li, Jiaxue Wang, Tan Zhang, 2019, Immunotherapy.

A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects

Y. An, Haifeng Song, Jie Lv, 2018, BioDrugs.

Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study

Yitong Wang, Q. Zheng, Zhe Xie, 2020 .

Drug pharmacokinetics in the obese population: challenging common assumptions on predictors of obesity-related parameter changes

C. Knibbe, E. Krekels, Cornelis Smit, 2022, Expert opinion on drug metabolism & toxicology.

A randomized controlled dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults.

Haifeng Song, Yitong Wang, Zhanguo Li, 2019, International immunopharmacology.

Probiotics for the treatment of women with bacterial vaginosis: A systematic review and meta-analysis of randomized clinical trials.

Lu-jin Li, Tenghua Wang, Yongmei Li, 2019, European journal of pharmacology.